Dr. Amit Bhanvadia, MD

Dr. Bhanvadia practices at North Orange County Surgery Center in Anaheim, California.

Dr. Bhanvadia's NPI, 1861751083, was assigned on May 8, 2012. Dr. Bhanvadia graduated from St. George's University School of Medicine in 2012. Dr. Bhanvadia holds California license A159586.

Dr. Bhanvadia's primary practice is North Orange County Surgery Center, at 1741 West Romneya Drive, Suite F, Anaheim, CA 92801. The practice phone is (714) 772-2891.

Dr. Bhanvadia's primary practice is North Orange County Surgery Center in Anaheim, California. Dr. Bhanvadia is also affiliated with UCI Health - Orange. The medical group on file is OC Gastro Care. Dmand AI also links Dr. Bhanvadia to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhanvadia practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bhanvadia's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bhanvadia is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bhanvadia's licenses on file in 2 states: California and New York.

Dmand AI lists chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastrointestinal bleeding, hemorrhoids, liver disease and upper GI endoscopy among the conditions Dr. Bhanvadia treats.

CMS data shows 403 Medicare services from Dr. Bhanvadia across 8 procedure codes in 2024, for 227 Medicare patients. Medicare paid $38,201 for them.

CMS counts 227 Medicare patients who saw Dr. Bhanvadia in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhanvadia's median patient age at 59, with 56% women.

In 2024, Dr. Bhanvadia wrote 100 Medicare Part D claims for 40 patients. 80% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $354 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

Dr. Bhanvadia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 61 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bhanvadia, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Bhanvadia, published from 2016 to 2017. 2016 was the busiest year, with 2. Dr. Bhanvadia's most frequent co-authors are Samy I. McFarlane, MD, Abhimanyu N. Amarnani, MD, PhD and Ayse Aytaman, MD.

CMS Open Payments shows 237 general payments to Dr. Bhanvadia from 26 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,278. It also lists 3 research payments totaling $16,649 from 2024 to 2025, naming 2 clinical trials.

Dr. Bhanvadia graduated from St. George's University School of Medicine in 2012.

Dr. Bhanvadia is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.